Výsledky vyhledávání - "Heditsian, D."

Akademický článek

Pathologic complete response (pCR) rates for patients with HR+/HER2− high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial

Publikováno v: In Annals of Oncology

Zobrazit plný text záznamu

Akademický článek

374P Evaluation of symptom severity, tolerability, and physical function in the I-SPY2 trial

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S332-S333

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ , and healthy women.

Autor: McCune E; Department of Surgery, University of California, San Francisco, California, USA., Sharma A; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA., Johnson B; Department of Surgery, University of California, San Francisco, California, USA., O'Meara T; Department of Surgery, University of California, San Francisco, California, USA., Theiner S; Department of Surgery, University of California, San Francisco, California, USA., Campos M; Department of Surgery, University of California, San Francisco, California, USA., Heditsian D; Department of Surgery, University of California, San Francisco, California, USA., Brain S; Department of Surgery, University of California, San Francisco, California, USA., Gilbert JA; Department of Pediatrics, University of California, San Diego, California, USA., Esserman L; Department of Surgery, University of California, San Francisco, California, USA., Campbell MJ; Department of Surgery, University of California, San Francisco, California, USA.

Publikováno v: MSystems [mSystems] 2024 Nov 19; Vol. 9 (11), pp. e0123724. Date of Electronic Publication: 2024 Oct 29.

Zobrazit plný text záznamu

Akademický článek

Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.

Autor: Shatsky RA; University of California San Diego, San Diego, CA, USA., Trivedi MS; Columbia University, New York, NY, USA., Yau C; University of California San Francisco, San Francisco, CA, USA., Nanda R; University of Chicago, Chicago, IL, USA., Rugo HS; University of California San Francisco, San Francisco, CA, USA., Davidian M; North Carolina State University, Raleigh, NC, USA., Tsiatis B; North Carolina State University, Raleigh, NC, USA., Wallace AM; University of California San Diego, San Diego, CA, USA., Chien AJ; University of California San Francisco, San Francisco, CA, USA., Stringer-Reasor E; University of Alabama at Birmingham, Birmingham, AL, USA., Boughey JC; The Mayo Clinic, Rochester, MN, USA., Omene C; Cooperman Barnabas Medical Center, New Brunswick, NJ, USA.; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Rozenblit M; Yale University, New Haven, CT, USA., Kalinsky K; Emory University, Atlanta, GA, USA., Elias AD; University of Colorado, Denver, CO, USA., Vaklavas C; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Beckwith H; University of Minnesota, Minneapolis, MN, USA., Williams N; The Ohio State University, Columbus, OH, USA., Arora M; University of California Davis, Davis, CA, USA., Nangia C; HOAG Family Cancer Institute, Newport Beach, CA, USA., Roussos Torres ET; University of Southern California, Los Angeles, CA, USA., Thomas B; Sparrow Health System, Lansing, MI, USA., Albain KS; Loyola University Chicago Stritch School of Medicine, Chicago, IL, USA., Clark AS; University of Pennsylvania, Philadelphia, PA, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Hershman DL; Columbia University, New York, NY, USA., Isaacs C; Lombardi Comprehensive Cancer Center Georgetown University, Washington, DC, USA., Thomas A; Wake Forest University, Winston-Salem, NC, USA., Tseng J; City of Hope Orange County Lennar Foundation Cancer Center, Irvine, CA, USA., Sanford A; Sanford Health, Sioux Falls, SD, USA., Yeung K; University of California San Diego, San Diego, CA, USA., Boles S; University of California San Diego, San Diego, CA, USA., Chen YY; University of California San Francisco, San Francisco, CA, USA., Huppert L; University of California San Francisco, San Francisco, CA, USA., Jahan N; University of Alabama at Birmingham, Birmingham, AL, USA., Parker C; University of Alabama at Birmingham, Birmingham, AL, USA., Giridhar K; The Mayo Clinic, Rochester, MN, USA., Howard FM; University of Chicago, Chicago, IL, USA., Blackwood MM; Cooperman Barnabas Medical Center, New Brunswick, NJ, USA., Sanft T; Yale University, New Haven, CT, USA., Li W; University of California San Francisco, San Francisco, CA, USA., Onishi N; University of California San Francisco, San Francisco, CA, USA., Asare AL; University of California San Francisco, San Francisco, CA, USA.; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Beineke P; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Norwood P; Quantum Leap Healthcare Collaborative, San Francisco, CA, USA., Brown-Swigart L; University of California San Francisco, San Francisco, CA, USA., Hirst GL; University of California San Francisco, San Francisco, CA, USA., Matthews JB; University of California San Francisco, San Francisco, CA, USA., Moore B; Wake Forest University, Winston-Salem, NC, USA., Symmans WF; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Price E; University of California San Francisco, San Francisco, CA, USA., Heditsian D; University of California San Francisco, San Francisco, CA, USA., LeStage B; University of California San Francisco, San Francisco, CA, USA., Perlmutter J; The Gemini Group, Ann Arbor, MI, USA., Pohlmann P; University of Texas MD Anderson Cancer Center, Houston, TX, USA., DeMichele A; University of Pennsylvania, Philadelphia, PA, USA., Yee D; University of Minnesota, Minneapolis, MN, USA., van 't Veer LJ; University of California San Francisco, San Francisco, CA, USA., Hylton NM; University of California San Francisco, San Francisco, CA, USA., Esserman LJ; University of California San Francisco, San Francisco, CA, USA. laura.esserman@ucsf.edu.

Publikováno v: Nature medicine [Nat Med] 2024 Sep 14. Date of Electronic Publication: 2024 Sep 14.

Zobrazit plný text záznamu

Akademický článek

Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer.

Autor: Northrop A; Department of Surgery, University of California San Francisco, San Francisco, CA 94158, United States., Christofferson A; Department of Surgery, University of California San Francisco, San Francisco, CA 94158, United States., Umashankar S; Department of Surgery, University of California San Francisco, San Francisco, CA 94158, United States., Melisko M; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94158, United States., Castillo P; Department of Surgery, University of California San Francisco, San Francisco, CA 94158, United States., Brown T; Patient Advocate, Breast Science Advocacy Core, University of California San Francisco, San Francisco, CA 94158, United States., Heditsian D; Patient Advocate, Breast Science Advocacy Core, University of California San Francisco, San Francisco, CA 94158, United States., Brain S; Patient Advocate, Breast Science Advocacy Core, University of California San Francisco, San Francisco, CA 94158, United States., Simmons C; Patient Advocate, Breast Science Advocacy Core, University of California San Francisco, San Francisco, CA 94158, United States., Hieken T; Division of Breast and Melanoma Surgical Oncology, Mayo Clinic, Rochester, MN 55905, United States., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States., Mainor C; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, United States., Afghahi A; Department of Medicine, University of Colorado, Aurora, CO 80045, United States., Tevis S; Department of Surgery, University of Colorado, Aurora, CO 80045, United States., Blaes A; Department of Medicine, Division of Hematology/Oncology, University of Minnesota, Minneapolis, MN 55455, United States., Kang I; Department of Medical Oncology & Therapeutics Research, City of Hope Orange County, Irvine, CA 92618, United States.; Department of Medicine, University of Southern California, Los Angeles, CA 90089, United States., Asare A; Department of Surgery, University of California San Francisco, San Francisco, CA 94158, United States.; Quantum Leap Healthcare Collaborative, San Francisco, CA 94158, United States., Esserman L; Department of Surgery, University of California San Francisco, San Francisco, CA 94158, United States., Hershman DL; Division of Hematology/Oncology, Department of Medicine, Columbia University, New York, NY 10032, United States., Basu A; Department of Surgery, University of California San Francisco, San Francisco, CA 94158, United States.

Publikováno v: Journal of the American Medical Informatics Association : JAMIA [J Am Med Inform Assoc] 2024 Aug 19. Date of Electronic Publication: 2024 Aug 19.

Zobrazit plný text záznamu

Akademický článek

¹⁸ F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy.

Autor: Diwanji D; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Onishi N; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Hathi DK; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Lawhn-Heath C; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Kornak J; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Li W; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Guo R; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Molina-Vega J; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Seo Y; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Flavell RR; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Heditsian D; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Brain S; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Esserman LJ; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Joe BN; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Hylton NM; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Jones EF; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.)., Ray KM; From the Departments of Radiology and Biomedical Imaging (D.D., N.O., D.K.H., C.L.H., W.L., R.G., Y.S., R.R.F., B.N.J., N.M.H., E.F.J., K.M.R.), Epidemiology and Biostatistics (J.K.), and Surgery (J.M.V., L.J.E.), University of California San Francisco, 550 16th St, San Francisco, CA 94158; and I-SPY 2 Advocacy Group, San Francisco, Calif (D.H., S.B.).

Publikováno v: Radiology. Imaging cancer [Radiol Imaging Cancer] 2024 Mar; Vol. 6 (2), pp. e230082.

Zobrazit plný text záznamu

Akademický článek

Receiving a Pathogenic Variant in a Population Breast Cancer Screening Trial: A Mixed Method Study.

Autor: Riddle L; Department of Humanities and Social Sciences, UCSF, San Francisco, California, USA., James JE; Institute for Health and Aging, UCSF, San Francisco, California, USA., Naeim A; Division of Hematology-Oncology, Center for SMART Health, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Madlensky L; Moores Cancer Center, Family Cancer Genetics Program, University of California, San Diego, California, USA., Brain S; Breast Science Advocacy Core, University of California, San Francisco, California, USA., DeRosa D; Moores Cancer Center, Family Cancer Genetics Program, University of California, San Diego, California, USA., Eklund M; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden., Fiscalini AS; Department of Surgery, University of California, San Francisco, California, USA., Heditsian D; Breast Science Advocacy Core, University of California, San Francisco, California, USA., Koenig B; Institute for Health and Aging, Department of Humanities and Social Sciences, UCSF, San Francisco, California, USA., Ross K; Cancer Genetics and Prevention Program, University of California, San Francisco, California, USA., Sabacan LP; Department of Surgery, University of California, San Francisco, California, USA., Tong B; Cancer Genetics and Prevention Program, University of California, San Francisco, California, USA., Wenger N; Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, California, USA., Joseph G; Department of Humanities and Social Sciences, UCSF, San Francisco, California, USA.

Publikováno v: Public health genomics [Public Health Genomics] 2024; Vol. 27 (1), pp. 177-196. Date of Electronic Publication: 2024 Sep 20.

Zobrazit plný text záznamu

Akademický článek

Patient perspectives on window of opportunity clinical trials in early-stage breast cancer.

Autor: Parikh DA; Department of Medicine, Stanford University, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA. divyaa@stanford.edu.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA. divyaa@stanford.edu., Kody L; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Brain S; Department of Medicine, Stanford University, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Heditsian D; Department of Medicine, Stanford University, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Lee V; Department of Medicine, Stanford University, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Curtis C; Department of Medicine, Stanford University, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Karin MR; Department of Surgery, Stanford University, Stanford, CA, USA., Wapnir IL; Department of Surgery, Stanford University, Stanford, CA, USA., Patel MI; Department of Medicine, Stanford University, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA., Sledge GW Jr; Department of Medicine, Stanford University, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA, USA., Caswell-Jin JL; Department of Medicine, Stanford University, 875 Blake Wilbur Drive, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University, Stanford, CA, USA.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jul; Vol. 194 (1), pp. 171-178. Date of Electronic Publication: 2022 May 11.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání